Drug Shortage Report for TRULICITY

Last updated on 2025-01-10 History
Report ID 211404
Drug Identification Number 02448602
Brand name TRULICITY
Common or Proper name dulaglutide
Company Name ELI LILLY CANADA INC
Market Status MARKETED
Active Ingredient(s) DULAGLUTIDE
Strength(s) 1.5MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 4 x 0.5 mL single-use prefilled pen
ATC code A10BJ
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Demand increase for the drug.
Anticipated start date 2024-01-04
Actual start date 2024-01-04
Estimated end date 2025-06-30
Actual end date
Shortage status Actual shortage
Updated date 2025-01-10
Company comments Due to demand uncertainties in the market, an allocation strategy has been implemented. Availability dates at a pharmacy’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their distributor to obtain the product availability date at the distributor, or to contact our Lilly Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays) for more information.
Health Canada comments
Tier 3 Status No
Contact Address EXCHANGE TOWER, 130 KING STREET WEST
TORONTO, ONTARIO
CANADA M5X 1B1
Company contact information Lilly Canada’s Customer Response Centre 1-888-545-5972.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2023-11-24 English Compare

Showing 21 to 21 of 21